CLARITY Act Passage Odds Decline as Spain Blocks Prediction Markets Regulatory Uncertainty Looms Scotiabank Flags Lower Rent Growth Expectations for MidAmerica Apartment Communities MAA AnheuserBusch InBev Shares Decline on Sales Miss Consumer Spending Shows Resilience but Rising Gas Prices Pose Potential Headwind Retail Dive FM Sitharaman Urges SIDBI to Evolve from Lender to Market Maker and RiskSharing Partner Notes Excise Duty Cut Impact of Over 1 Lakh Crore Bitcoin Beyond Speculation Institutional Adoption Reshapes Cryptos Role in Finance Magyar Bancorp Inc MGYR Q4 2025 Earnings Bank Reports EPS of 040 Amid Quiet Quarter EPAM Systems Q1 2026 Earnings Solid EPS Beat Amid Cautious Demand Bar Harbor Bankshares Inc Q1 2026 Earnings Missed EPS Estimates Amid Cautious Start to the Year Arch Capital Group Q1 2026 Earnings EPS Misses Consensus by a Small Margin Shares Edge Higher BRBI Q1 2026 Earnings Significant EPS Miss Sends Stock Lower CCC Q1 2026 Earnings EPS Beats Estimates by Nearly 15 Amid Strategic Progress Altisource Portfolio Solutions Warrants ASPSZ Edges Lower as Tight Trading Range Persists ING Group Slips 05 as Shares Test Key Support at 2897 Manchester United Shares Slip Amid Performance Concerns MDxHealth MDXH Slides 625 as Cancer Diagnostics Stock Tests Key Support Level REAL Shows Modest Gains Amid Consolidation Key Levels in Focus FMNB Q1 2026 Earnings Strong EPS Surprise of 212 Drives Investor Attention Despite Stock Dip OMER Q1 2026 Earnings NarrowerThanExpected Loss Despite No Reported Revenue Shares Dip 42 LNKB Q4 2025 Earnings EPS Falls 57 Short of Estimates Shares Flat American Eagle Outfitters AEO Q1 2026 Earnings EPS Surges Past Estimates Shares Edge Higher WD40 Company WDFC Q1 2026 Earnings EPS Beats Estimates as Company Maintains Steady Growth BELFA Q1 2026 Earnings EPS Surpasses Estimates Stock Rises on Strong Performance Indian Corporate Balance Sheets Show Maturation Interest Coverage Ratio Trends Signal Improved Financial Health First Bancorp FBNC Q1 2026 Earnings EPS Slightly Beats Estimates Amid Stable Operations Spero Therapeutics SPRO Jumps 49 as Stock Approaches Key Resistance at 315